Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 278


Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.

Schnabel R, Fijten R, Smolinska A, Dallinga J, Boumans ML, Stobberingh E, Boots A, Roekaerts P, Bergmans D, van Schooten FJ.

Sci Rep. 2015 Nov 26;5:17179. doi: 10.1038/srep17179.


Electronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia.

Schnabel RM, Boumans ML, Smolinska A, Stobberingh EE, Kaufmann R, Roekaerts PM, Bergmans DC.

Respir Med. 2015 Nov;109(11):1454-9. doi: 10.1016/j.rmed.2015.09.014. Epub 2015 Sep 30.


Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial.

Collins CD, Schwemm AK.

Value Health. 2015 Jul;18(5):614-21. doi: 10.1016/j.jval.2015.04.007. Epub 2015 Jun 12.


[Validity comparison of various biological samples from lower airway and their contribution for the detection of nosocomial pneumonia etiological agents].

Gabrhelík T, Hanulík V, Jakubec P, Uvízl R, Doubravská L, Röderová M, Adamus M, Kolek V, Kolář M.

Klin Mikrobiol Infekc Lek. 2015 Mar;21(1):4-9. Czech.


Rapid automated microscopy for microbiological surveillance of ventilator-associated pneumonia.

Douglas IS, Price CS, Overdier KH, Wolken RF, Metzger SW, Hance KR, Howson DC.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):566-73. doi: 10.1164/rccm.201408-1468OC.


Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms.

Van Laar TA, Chen T, You T, Leung KP.

Antimicrob Agents Chemother. 2015 Mar;59(3):1707-17. doi: 10.1128/AAC.04581-14. Epub 2015 Jan 12.


An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.

Patel DA, Michel A, Stephens J, Weber B, Petrik C, Charbonneau C.

Infect Drug Resist. 2014 Oct 24;7:273-80. doi: 10.2147/IDR.S68658. eCollection 2014.


Probiotics for preventing ventilator-associated pneumonia.

Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss RS, Kollef MH, Crooks NH, Deng X.

Cochrane Database Syst Rev. 2014 Oct 25;10:CD009066. doi: 10.1002/14651858.CD009066.pub2. Review.


A novel Pseudomonas aeruginosa strain with an oprD mutation in relation to a nosocomial respiratory infection outbreak in an intensive care unit.

Yan Y, Yao X, Li H, Zhou Z, Huang W, Stratton CW, Lu CD, Tang YW.

J Clin Microbiol. 2014 Dec;52(12):4388-90. doi: 10.1128/JCM.02782-14. Epub 2014 Oct 8.


Characterization and plasmid elimination of NDM-1-producing Acinetobacter calcoaceticus from China.

Sun Y, Liu Q, Chen S, Song Y, Liu J, Guo X, Zhu L, Ji X, Xu L, Zhou W, Qian J, Feng S.

PLoS One. 2014 Sep 2;9(9):e106555. doi: 10.1371/journal.pone.0106555. eCollection 2014.


Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Patel DA, Shorr AF, Chastre J, Niederman M, Simor A, Stephens JM, Charbonneau C, Gao X, Nathwani D.

Crit Care. 2014 Jul 22;18(4):R157. doi: 10.1186/cc13996.


The accuracy of Gram stain of respiratory specimens in excluding Staphylococcus aureus in ventilator-associated pneumonia.

Gottesman T, Yossepowitch O, Lerner E, Schwartz-Harari O, Soroksky A, Yekutieli D, Dan M.

J Crit Care. 2014 Oct;29(5):739-42. doi: 10.1016/j.jcrc.2014.05.011. Epub 2014 May 28.


Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).

Farrell DJ, Sader HS, Flamm RK, Jones RN.

Int J Antimicrob Agents. 2014 Jun;43(6):533-9. doi: 10.1016/j.ijantimicag.2014.01.032. Epub 2014 Mar 26.


Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.

Yokoyama Y, Matsumoto K, Ikawa K, Watanabe E, Shigemi A, Umezaki Y, Nakamura K, Ueno K, Morikawa N, Takeda Y.

Int J Antimicrob Agents. 2014 Jun;43(6):547-52. doi: 10.1016/j.ijantimicag.2014.02.012. Epub 2014 Mar 30.


A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.

Xia J, Zhang D, Xu Y, Gong M, Zhou Y, Fang X.

Int J Infect Dis. 2014 Jun;23:90-3. doi: 10.1016/j.ijid.2014.01.017. Epub 2014 Apr 12.


Development of a 4-valent genotyping assay for direct identification of the most frequent Pseudomonas aeruginosa serotypes from respiratory specimens of pneumonia patients.

Koch H, Emrich T, Jampen S, Wyss M, Gafner V, Lazar H, Rudolf MP.

J Med Microbiol. 2014 Apr;63(Pt 4):508-17. doi: 10.1099/jmm.0.066043-0. Epub 2014 Jan 15.


[Characterization of extended-spectrum β-lactamases-producing Klebsiella pneumoniae isolates of two intensive care units].

González AC, Nieves B, Solórzano M, Cruz J, Puig J, Moreno M.

Rev Chilena Infectol. 2013 Aug;30(4):374-80. doi: 10.4067/S0716-10182013000400004. Spanish.


Phenotypic and Genotypic Methods for Detection of Extended Spectrum β Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolated from Ventilator Associated Pneumonia.

Krishnamurthy V, G S V, Kumar M S, H V P, R P, E R N.

J Clin Diagn Res. 2013 Sep;7(9):1975-8. doi: 10.7860/JCDR/2013/6544.3376. Epub 2013 Sep 10.


Detection of drug-resistant Klebsiella pneumoniae in Chinese hares (Lepus sinensis).

Du Y, Luo J, Wang C, Wen Q, Duan M, Zhang H, He H.

J Wildl Dis. 2014 Jan;50(1):109-12. doi: 10.7589/2013-03-059. Epub 2013 Oct 25.


[Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].

Wang Q, Zhao CJ, Wang H, Yu YS, Zhu ZH, Chu YZ, Sun ZY, Hu ZD, Xu XL, Liao K, Xu YC, Zhang LY, Mei YN, Yang B, Ni YX.

Zhonghua Yi Xue Za Zhi. 2013 May 14;93(18):1388-96. Chinese.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk